Drug Shortage Report for TARO-BUPROPION XL
Report ID | 150065 |
Drug Identification Number | 02475804 |
Brand name | TARO-BUPROPION XL |
Common or Proper name | BUPROPION |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 90 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-09-23 |
Estimated end date | 2022-12-02 |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2022-12-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-12-07 | French | Compare |
v3 | 2021-12-07 | English | Compare |
v2 | 2021-11-26 | French | Compare |
v1 | 2021-11-26 | English | Compare |